INDEMNIFICATION AGREEMENTIndemnification Agreement • November 21st, 2016 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of __________ by and between ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), and ________________ (“Indemnitee”).
Endra, Inc. SUBSCRIPTION AGREEMENTSubscription Agreement • November 21st, 2016 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • California
WARRANT TO PURCHASE COMMON STOCK OF ENDRA, INC.ENDRA Life Sciences Inc. • November 21st, 2016 • Electromedical & electrotherapeutic apparatus • California
This certifies that __________________, or assigns (collectively, the “Holder”), for value received, is entitled to purchase, at an exercise price per share equal to $_____ (the “Exercise Price”), from ENDRA, INC., a Delaware corporation (the “Company”), up to ____________ (_________) fully paid and nonassessable shares of the Company’s Common Stock (the “Common Stock”). This Warrant shall be exercisable at any time from time to time from and after the date of issuance hereof (the “Issuance Date”) up to and including 5:00 p.m. (Pacific Time) on the first to occur of (i) the second (2nd) anniversary of the Issuance Date or (ii) on the closing date of a financing transaction resulting in the Company receiving gross proceeds of at least $5.0 million at a valuation, calculated prior to the date of consummation of the financing, of at least $10.0 million (a “Qualified Financing”) (such earlier date being referred to herein as the “Expiration Date”), upon surrender to the Company at its prin
EXCHANGE AGREEMENTExchange Agreement • November 21st, 2016 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • Delaware
This Agreement (“Agreement”) is entered into as of September __, 2014, by and between Endra, Inc., a Delaware corporation (the “Company”), and ______________ (the “Investor”).
AMENDMENT TO SUBLICENSE AGREEMENTSublicense Agreement • November 21st, 2016 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus
This Amendment (“Amendment”) to the Sublicense Agreement dated as of August 2, 2007 (the “Agreement”) by and among Endra, Inc., a Delaware corporation (“Endra”), and Optosonics, Inc. (“Optosonics”) is entered into on this 18th day of January, 2011 (the “Amendment Effective Date”). For purposes hereof, all capitalized terms used herein but not defined herein shall have the meanings given to them in the Agreement.
SUBLICENSE AGREEMENTSublicense Agreement • November 21st, 2016 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • Massachusetts
This Sublicense Agreement (“Agreement”) is entered as of the 2nd day of August, 2007 (“Effective Date”) by and between Optosonics, Inc. (“Optosonics”), a Delaware Corporation, with a place of business at 351 West 10th Street, Suite 250, Indianapolis, Indiana and Endra, Inc. (“Endra”), a Massachusetts corporation with a place of business at 222 Berkeley Street, Boston, Massachusetts 02116.
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • November 21st, 2016 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • New York
THIS AGREEMENT is made as of April 22, 2016 (“Effective Date”) by and between General Electric Company, acting through its GE Healthcare business and Global Research unit (“GE”), and ENDRA Inc. a Delaware corporation having its principal place of business at Ann Arbor, MI (“ENDRA”).
PROMISSORY NOTEPromissory Note • November 21st, 2016 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus
FOR VALUE RECEIVED, Endra, Inc., a Delaware corporation (“Borrower”), promises to pay to the order of ____________ (“Lender”) the principal sum of ________________ Dollars ($_______), or such other amount as shall have been advanced and be outstanding hereunder and remain unpaid, without interest thereon.
ANN ARBOR, MICHIGAN GROSS LEASEGross Lease • November 21st, 2016 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • Michigan
This Lease is made between Landlord and Tenant hereinafter identified in Sections 1(b) and 1(c) hereof, respectively, and constitutes a Lease between the parties of the “Demised Premises” in the “Building,” as defined in Sections 2.2 and 2.1 hereof, respectively, on the terms and conditions and with and subject to the covenants and agreements of the parties hereinafter set forth.
CONVERTIBLE PROMISSORY NOTEENDRA Life Sciences Inc. • November 21st, 2016 • Electromedical & electrotherapeutic apparatus
CONSULTING AGREEMENTConsulting Agreement • November 21st, 2016 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • California
THIS CONSULTING AGREEMENT (the “Agreement”) is entered into as of July 23, 2014, by and between Endra, Inc., a Michigan corporation (the “Company”), and StoryCorp Consulting, a Nevada corporation (“StoryCorp”).
WARRANT TO PURCHASE COMMON STOCK OF ENDRA, INC.ENDRA Life Sciences Inc. • November 21st, 2016 • Electromedical & electrotherapeutic apparatus • Delaware
This certifies that ___________, or assigns (collectively, the “Holder”), for value received, is entitled to purchase, at an exercise price per share equal to $5.72 (the “Exercise Price”), from ENDRA, INC., a Delaware corporation (the “Company”), up to ___________ (___________) fully paid and nonassessable shares (the “Warrant Shares”) of the Company’s Common Stock (the “Common Stock”). This Warrant shall be exercisable at any time from time to time from and after the date of issuance hereof (the “Issuance Date”) up to and including 5:00 p.m. (Pacific Time) on the fifth (5th) anniversary of the Issuance Date (such date being referred to herein as the “Expiration Date”), upon surrender to the Company at its principal office (or at such other location as the Company may advise the Holder in writing) of this Warrant properly endorsed with (i) the Form of Subscription attached hereto duly completed and executed and (ii) if applicable, payment pursuant to Section 4 of the aggregate Exercise
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 21st, 2016 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • California
This Securities Purchase Agreement (this “Agreement”), dated as of July 10, 2013, is by and between PureTech Ventures, LLC, a Delaware limited liability corporation (the “Seller”), and each purchaser identified on Schedule A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 21st, 2016 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • California
This Securities Purchase Agreement (this “Agreement”), dated as of July 10, 2013, is by and between Enlight Biosciences, LLC, a Delaware limited liability corporation (the “Seller”), and each purchaser identified on Schedule A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
